Integrin signaling, free radicals, and tyrosine kinase mediate flow constriction in isolated cerebral arteries.
Isolated, cannulated, and pressurized (100 mmHg) middle cerebral arteries from adult cats were perfused intraluminally at rates from 0 to 4 ml/min with heated and gassed physiological saline solution. An electronic system held pressure constant by changing outflow resistance. The arteries constricted 18.1 +/- 0.95% in response to flow and depolarized from -54 +/- 0.51 to -40 +/- 1.26 mV (P < 0.05). Constriction was independent of a functional endothelium but was eliminated by superoxide dismutase or tyrosine kinase inhibitors. Luminal perfusion with a synthetic extracellular matrix Arg-Gly-ASP (RGD) peptide that binds with integrin significantly reduced constriction to flow. Neither reducing intraluminal pressure nor increasing tone or shear stresses altered constriction to flow. Flow-induced constriction did not impede the ability of the arteries to dilate to hypercapnia, and inhibiting flow-induced constriction did not alter contractile responses to other agonists. These data suggest that, in vitro, middle cerebral arteries constrict to flow through a mechanism involving free radicals and tyrosine kinase and that flow shear stresses resulting in constriction are transduced by integrin signaling.
Madden
J A
JA
Department of Neurology, The Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA. jmadden@mcw.edu
Christman
N J
NJ
D000818:Animals; D001783:Blood Flow Velocity; D001794:Blood Pressure; D002415:Cats; D005260:Female; D066298:In Vitro Techniques; D016023:Integrins / Q000502:physiology*; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology; D020768:Middle Cerebral Artery / Q000187:drug effects / Q000502:physiology*; D009119:Muscle Contraction / Q000502:physiology; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D011505:Protein-Tyrosine Kinases / Q000378:metabolism*; D015398:Signal Transduction; D013314:Stress, Mechanical; D013482:Superoxide Dismutase / Q000494:pharmacology; D014655:Vascular Resistance; D014661:Vasoconstriction / Q000187:drug effects / Q000502:physiology*
D016023:Integrins; D013482:Superoxide Dismutase; D011505:Protein-Tyrosine Kinases; D019331:NG-Nitroarginine Methyl Ester